Species Differences in Tissue Distribution and Enzyme Activities of Arylacetamide Deacetylase in Human, Rat, and Mouse

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drug Metabolism And Disposition

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.111.043067PMID 22207054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.

  2011influential reference
• Arylacetamide Deacetylase Is a Determinant Enzyme for the Difference in Hydrolase Activities of Phenacetin and Acetaminophen

  2010influential reference
• Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins

  2010cited by this paper
• Human Arylacetamide Deacetylase Is a Principal Enzyme in Flutamide Hydrolysis

  2009influential reference
• Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes

  2008cited by this paper
• DETECTION OF A NEW N-OXIDIZED METABOLITE OF FLUTAMIDE, N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]HYDROXYLAMINE, IN HUMAN LIVER MICROSOMES AND URINE OF PROSTATE CANCER PATIENTS

  2006cited by this paper
• The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment

  2004cited by this paper
• Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate.

  2002cited by this paper
• Current progress on esterases: from molecular structure to function.

  2002cited by this paper
• Characterization of the Rodent Genes for Arylacetamide Deacetylase, a Putative Microsomal Lipase, and Evidence for Transcriptional Regulation* 210

  2001cited by this paper
• Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes

  2000cited by this paper
• Regular use of analgesics is a risk factor for renal cell carcinoma

  1999cited by this paper
• Purification and characterization of pranlukast hydrolase from rat liver microsomes: the hydrolase is identical to carboxylesterase pI 6.2.

  1997cited by this paper
• Clinically Significant Drug Interactions with Antituberculosis Agents

  1994cited by this paper
• Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase.

  1994cited by this paper
• The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.

  1991cited by this paper
• Mutagenic and analgesic activities of aniline derivatives.

  1991cited by this paper
• Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

  1989cited by this paper
• [A simultaneous determination of rifampin and 25-deacetylrifampicin in cerebrospinal fluid and plasma of rabbit by liquid chromatography].

  1987cited by this paper
• Isoniazid, rifampin, and hepatotoxicity.

  1986cited by this paper
• Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes.

  1983influential reference
• Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.

  1982cited by this paper
• Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.

  1980cited by this paper
• SPECIES DIFFERENCES IN MICROSOMAL ACTIVATION OF MUTAGENS AND CARCINOGENS, WITH SPECIAL REFERENCE TO NEW POTENT MUTAGENS FROM PYROLYSATES OF AMINO ACIDS AND PROTEINS

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose

  1975cited by this paper
• Disposition of a new, nonsteroid, antiandrogen, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide (Flutamide), in men following a single oral 200 mg dose.

  1975cited by this paper
• Rifampicin, a general review.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Arylacetamide deacetylase deficiency potentiates ketoconazole-induced inhibition of triazolam metabolism in mice

  2026cites this paper
• Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics.

  2026cites this paper
• Progress of arylacetamide deacetylase research in metabolic diseases

  2025cites this paper
• Pharmacokinetics and pre-systemic biotransformation of a deuterated clopidogrel-ferulic acid conjugate in rats.

  2025cites this paper
• Revealing drug interactions: A computational study of non-P450 metabolizing enzymes.

  2025cites this paper
• Arylacetamide deacetylase regulates hepatic iron homeostasis to protect against carbon tetrachloride-induced ferroptosis

  2024cites this paper
• Ocular drug-metabolizing enzymes: focus on esterases

  2024cites this paper
• Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation.

  2024cites this paper
• Pharmacokinetic/Pharmacodynamic Assessment of the Structural Refinement of Clopidogrel Focusing on the Balance between Bioactivation and Deactivation

  2024cites this paper
• Characterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone.

  2024cites this paper
• Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism.

  2023cites this paper
• Targeted Protein Degraders- The druggability perspective.

  2023cites this paper
• Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies.

  2023cites this paper
• ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.

  2023cites this paper
• Intracellular spatiotemporal metabolism in connection to target engagement.

  2023cites this paper
• In Vitro Evaluation of the Reductase Activities of Human AKR1C3 Allelic Variants

  2023cites this paper
• Development and Validation of a Proteomic Correlation Profiling Technique to Detect and Identify Enzymes Involved in Metabolism of Drugs of Concern

  2023cites this paper
• Quantitative Prediction of OATP-Mediated Disposition and Biliary Clearance Using Human Liver Chimeric Mice

  2023cites this paper
• In vitro deacetylation of N‐acetylserotonin by arylacetamide deacetylase

  2023cites this paper
• Characterization of Enzymes Involved in Nintedanib Metabolism in Humans

  2023cites this paper
• ncBAF, a chromatin remodeler, enhances PXR-mediated transcriptional activation in the human and mouse liver

  2023cites this paper
• PPARα regulates the expression of human arylacetamide deacetylase involved in drug hydrolysis and lipid metabolism.

  2022cites this paper
• Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer

  2022cites this paper
• Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer

  2022cites this paper
• Species differences in liver microsomal hydrolysis of acyl glucuronide in humans and rats

  2022cites this paper
• KIAA1363—A Multifunctional Enzyme in Xenobiotic Detoxification and Lipid Ester Hydrolysis

  2022cites this paper
• Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma

  2022cites this paper
• Characterization, comparative, and functional analysis of arylacetamide deacetylase from Gnathostomata organisms

  2022cites this paper
• Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiency.

  2021cites this paper
• Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.

  2021cites this paper
• Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins

  2021cites this paper
• Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans.

  2021cites this paper
• Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC.

  2021cites this paper
• Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound?

  2021cites this paper
• Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer

  2021cites this paper
• Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of AADAC Genetic Polymorphisms on Hydrolase Activity

  2021cites this paper
• Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues

  2021cites this paper
• Identification of an isoform catalyzing the CoA conjugation of nonsteroidal anti-inflammatory drugs and the evaluation of the expression levels of acyl-CoA synthetases in the human liver.

  2020cites this paper
• Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid.

  2020cites this paper
• A generic PBTK model implemented in the MCRA platform: Predictive performance and uses in risk assessment of chemicals.

  2020cites this paper
• Identi cation of prognostic genes after platinum- based chemotherapy in ovarian cancer

  2020cites this paper
• Strain and sex differences in drug hydrolase activities in rodent livers.

  2019cites this paper
• DeepNEU: cellular reprogramming comes of age – a machine learning platform with application to rare diseases research

  2019cites this paper
• Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation.

  2019cites this paper
• Carboxylesterase 2 and Intestine Transporters Contribute to the Low Bioavailability of Allisartan, a Prodrug of Exp3174 for Hypertension Treatment in Humans

  2019cites this paper
• Characterization of human UGT2A3 expression using a prepared specific antibody against UGT2A3.

  2019cites this paper
• Arylacetamide Deacetylase Enzyme: Presence and Interindividual Variability in Human Lungs

  2019cites this paper
• Development and evaluation of a harmonized whole body physiologically based pharmacokinetic (PBPK) model for flutamide in rats and its extrapolation to humans.

  2019cites this paper
• Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?

  2019cites this paper
• Human Efflux Transporters in Drug Disposition : in vitro Transport of Glucuronide Metabolites

  2019cites this paper
• The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets

  2019cites this paper
• Arylacetamide deacetylase (AADAC) enzyme: presence and inter-individual variability in human lungs

  2019influential citation
• Aspirin Attenuates the Bioactivation of and Platelet Response to Vicagrel in Mice

  2018cites this paper
• Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans

  2018cites this paper
• Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen.

  2018cites this paper
• Metabolic Hydrolysis of Aromatic Amides in Selected Rat, Minipig, and Human In Vitro Systems

  2018cites this paper
• Pharmacokinetic Herb-Drug Interactions involving african traditional medicines - fingerprint analysis and in vitro metabolism studies

  2018cites this paper
• Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis

  2018cites this paper
• In vitro approach to elucidate the relevance of carboxylesterase 2 and N‐acetyltransferase 2 to flupirtine‐induced liver injury

  2018cites this paper
• Identification of enzymes responsible for nitrazepam metabolism and toxicity in human

  2017cites this paper
• Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction Predictions

  2017cites this paper
• Evaluation of Expression and Glycosylation Status of UGT1A10 in Supersomes and Intestinal Epithelial Cells with a Novel Specific UGT1A10 Monoclonal Antibody

  2017cites this paper
• Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity.

  2016cites this paper
• Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog

  2016cites this paper
• Microsoft Word-68931795-file00.docx

  2015cites this paper
• DMD064089 1218..1225

  2015cites this paper
• [Role of Human Orphan Esterases in Drug-induced Toxicity].

  2015cites this paper
• Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase

  2015cites this paper
• A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody production.

  2015cites this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015cites this paper
• Metabolism elucidation of BJ-B11 (a heat shock protein 90 inhibitor) by human liver microsomes: identification of main contributing enzymes

  2015cites this paper
• Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as A Rat-Specific Diltiazem Deacetylase

  2015cites this paper
• Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as A Rat-Specific Diltiazem Deacetylase

  2015cites this paper
• Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats

  2015cites this paper
• Isolation and characterization of arylacetamide deacetylase in cynomolgus macaques

  2015influential citation
• Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as A Rat-Specific Diltiazem Deacetylase

  2015cites this paper
• Bioconversion of the prodrug olmesartan medoxomil via carboxymethylene- butenolidase and paraoxonase 1

  2014cites this paper
• The effect of dietary intake of the acidic protein fraction of bovine colostrum on influenza A (H1N1) virus infection

  2013cites this paper
• Modelling human disease with pluripotent stem cells.

  2013cites this paper
• Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia.

  2012cites this paper
• Contributions of Arylacetamide Deacetylase and Carboxylesterase 2 to Flutamide Hydrolysis in Human Liver

  2012influential citation
• Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females.

  2012cites this paper
• The emerging role of human esterases.

  2012cites this paper